Zum Inhalt springen
LURIC

Publikation · PMID 21047199

Impact of CYP2C8 and 2C9 polymorphisms on coronary artery disease and myocardial infarction in the LURIC cohort

Haschke-Becher E, Kirchheiner J, Trummer O, Grünbacher G, Kainz A, Boehm BO, März W, Renner W

CYP2C8 and CYP2C9 polymorphisms were genotyped in 2827 LURIC patients to examine associations with coronary artery disease (CAD) and myocardial infarction (MI). Overall variant frequencies did not differ between cases and controls, though CYP2C9*3 conferred increased MI risk in men (OR 1.67, p = 0.03) and decreased CAD risk in women (OR 0.65, p = 0.05). The results support no major cardiovascular risk from these variants in coronary angiography patients.

Pharmacogenomics, Oktober 2010 | PMID 21047199

Zeitschrift
Pharmacogenomics
DOI
10.2217/pgs.10.96
PMID
21047199
Quelle
https://pubmed.ncbi.nlm.nih.gov/21047199/
Zitationen
16 Relative Zitationsrate 0.48 (1,0 = Durchschnitt des Fachgebiets) · NIH iCite, Stand 23.08.2026